From: Occurrence of breast cancer subtypes in adolescent and young adult women
Characteristics | Total rate (95% CI)b | HR+/HER2- rate (95% CI) | HR+/HER2+ rate (95% CI) | HR-/HER2+ rate (95% CI) | Triple-negative rate (95% CI) |
---|---|---|---|---|---|
Age group (years) | Â | Â | Â | Â | Â |
   15-24 | 0.7 (0.6-0.9) | 0.3 (0.2-0.4) | 0.1 (0.0-0.2) | 0.1 (0.0-0.2) | 0.1 (0.0-0.2) |
   25-29 | 7.4 (6.8-8.1) | 2.5 (2.1-2.9) | 1.2 (1.0-1.5) | 0.8 (0.6-1.1) | 1.5 (1.2-1.8) |
   30-34 | 24.4 (23.2-25.7) | 9.0 (8.3-9.8) | 4.0 (3.5-4.5) | 2.3 (2.0-2.7) | 5.2 (4.6-5.8) |
   35-39 | 54.5 (52.7-56.3) | 24.0 (22.8-25.2) | 7.8 (7.1-8.5) | 4.3 (3.8-4.8) | 10.0 (9.2-10.8) |
Race/ethnicity | Â | Â | Â | Â | Â |
   White | 21.0 (20.2-21.9) | 9.2 (8.7-9.8) | 3.0 (2.7-3.4) | 1.7 (1.5-2.0) | 3.8 (3.4-4.1) |
   Black | 21.8 (19.7-23.9) | 7.0 (5.9-8.3) | 3.4 (2.6-4.3) | 2.0 (1.4-2.8) | 6.1 (5.0-7.3) |
   Hispanic | 15.8 (15.1-16.6) | 6.0 (5.6-6.5) | 2.4 (2.1-2.7) | 1.4 (1.2-1.7) | 3.4 (3.1-3.8) |
   Asian | 19.4 (18.1-20.7) | 9.0 (8.2-9.9) | 3.2 (2.7-3.8) | 1.6 (1.3-2.1) | 2.4 (2.0-2.9) |
   Incidence rate ratio |  |  |  |  |  |
White | Reference | Reference | Reference | Reference | Reference |
Black | 1.04 (0.93-1.16) | 0.76 (0.63-0.91) | 1.11 (0.85-1.44) | 1.18 (0.83-1.66) | 1.61 (1.31-1.97) |
Hispanic | 0.75 (0.70-0.81) | 0.65 (0.54-0.79) | 0.78 (0.60-1.02) | 0.83 (0.58-1.17) | 0.91 (0.74-1.12) |
Asian | 0.92 (0.84-1.01) | 0.98 (0.87-1.10) | 1.05 (0.86-1.28) | 0.95 (0.73-1.25) | 0.64 (0.52-0.79) |
AJCC Stage at diagnosis | Â | Â | Â | Â | |
   I | 4.9 (4.6-5.1) | 2.5 (2.3-2.6) | 0.6 (0.5-0.7) | 0.3 (0.3-0.4) | 0.7 (0.6-0.8) |
   II | 8.2 (7.9-8.5) | 3.3 (3.0-3.5) | 1.2 (1.1-1.4) | 0.7 (0.6-0.8) | 1.8 (1.7-2.0) |
   III | 3.7 (3.5-3.9) | 1.5 (1.3-1.6) | 0.7 (0.6-0.8) | 0.4 (0.3-0.5) | 0.7 (0.6-0.8) |
   IV | 1.1 (1.0-1.2) | 0.4 (0.4-0.5) | 0.2 (0.1-0.2) | 0.1 (0.1-0.2) | 0.2 (0.2-0.3) |
Grade | Â | Â | Â | Â | Â |
Low | 7.5 (7.2-7.8) | 4.7 (4.4-4.9) | 1.1 (1.0-1.3) | 0.3 (0.3-0.4) | 0.3 (0.3-0.4) |
High | 10.2 (9.8-10.6) | 2.9 (2.7-3.1) | 1.6 (1.4-1.7) | 1.2 (1.1-1.3) | 3.2 (3.0-3.4) |
Tumor size | Â | Â | Â | Â | Â |
≤2 cm | 7.3 (7.0-7.7) | 3.6 (3.4-3.8) | 1.1 (1.0-1.2) | 0.5 (0.4-0.6) | 1.1 (1-1.2) |
> 2 cm | 10.4 (10.0-10.8) | 4.0 (3.8-4.2) | 1.6 (1.5-1.8) | 0.9 (0.8-1.1) | 2.4 (2.2-2.5) |
Microinvasion | 0.2 (0.1-0.2) | c | c | c | c |
Diffuse | 0.1 (0.1-0.2) | c | c | c | c |
Lymph node involvement | Â | Â | Â | Â | |
No | 9.3 (9.0 - 9.7) | 3.9 (3.7-4.2) | 1.2 (1.1-1.3) | 0.6 (0.5-0.7) | 1.9 (1.8-2.1) |
Positive | 9.1 (8.8 - 9.5) | 3.8 (3.6-4.0) | 1.6 (1.4-1.7) | 1.0 (0.9-1.1) | 1.7 (1.5-1.8) |
Prior cancer | Â | Â | Â | Â | Â |
First primary | 17.7 (17.2 - 18.2) | 7.4 (7.1-7.7) | 2.7 (2.5-2.9) | 1.5 (1.4-1.7) | 3.3 (3.1-3.6) |
Non-first primary | 1.9 (1.7 - 2.1) | 0.7 (0.6-0.8) | 0.3 (0.2-0.3) | 0.2 (0.1-0.2) | 0.4 (0.3-0.5) |
Total | 18.9 (18.4 - 19.4) | 7.8 (7.5-8.2) | 2.8 (2.6-3.0) | 1.6 (1.5-1.8) | 3.6 (3.4-3.8) |